Day: May 23, 2026

Biometric Biomarkers in Psychedelic Medicine: Utilizing EEG Data to Predict Ketamine Efficacy

Introduction The burgeoning field of psychedelic medicine – encompassing substances like psilocybin and LSD – presents exciting possibilities for treating a range of mental health conditions, from depression and anxiety to PTSD and addiction. However, the complex interplay between these substances and individual responses remains largely unexplored. Traditional methods of assessing efficacy, such as questionnaires […]